Omega XL Announces New Published Study: Omega-3 DHA Prevents Age-Related Vision Loss

A new study published in Investigative Ophthalmology & Visual Science suggests Omega-3 essential fatty acid DHA, such as found in Omega XL, counteracts the buildup of toxins in the retina preventing age-related vision loss.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
At 12 months the researchers noted that DHA prevented the accumulation of a toxic molecule in retinal pigment epithelial (RPE) that normally builds up with age that can cause retina disease and vision loss.

Fort Lauderdale, FL (PRWEB) June 11, 2012

According to a new study, peer reviewed and published in the Journal of Investigative Ophthalmology & Visual Science (http://www.iovs.org/content/53/4/2256), docosahexaenoic acid (DHA), one of the omega-3 essential fatty acids found in cold water fish and fish oil supplements such as Omega XL, prevented age-related vision loss in lab tests.

The lead researcher in the Faculty of Medicine & Dentistry, Yves Sauvé, and his team studied the effect of dietary supplementation with DHA using a transgenic mouse model. At 12 months the researchers noted that DHA prevented the accumulation of a toxic molecule in retinal pigment epithelial (RPE) that normally builds up with age that can cause retina disease and vision loss. Sauvé and his team concluded that supplemental DHA could act on pathologic and normal age-related processes.

"This discovery could result in a very broad therapeutic use," Sauvé said in a statement. "In normal aging, this toxin increases twofold as we age. But in lab tests, there was no increase in this toxin whatsoever. This has never been demonstrated before - that supplementing the diet with DHA could make this kind of difference."

Another study is underway by Sauvé and his research team to look at people who have age-related macular degeneration, a condition that results in loss of central vision and is the main cause of blindness in people over the age of 50. The researchers will look for DNA markers in the blood of study participants. The team wants to determine whether participants with certain genetic markers will respond better to increasing amounts of DHA in their diet, and if so, why.

Omega XL is a bestselling Omega 3 supplement that contains the patented stabilized marine lipid extract PCSO-524™ derived only from the New Zealand green-lipped mussel with 30 healthy fatty acids including DHA and EPA. Omega XL, manufactured exclusively by Great HealthWorks Inc., is the most widely available omega-3 fish oil supplement containing the potent PCSO-524™ marine lipid extract. To find more information about Omega XL and PCSO-524™ visit http://www.OmegaXL.com

Source: Investigative Ophthalmology & Visual Science
B. Dornstauder, M. Suh, S. Kuny, F. Gaillard, I. M. MacDonald, M. T. Clandinin, Y. Sauve. Dietary Docosahexaenoic Acid Supplementation Prevents Age-Related Functional Losses and A2E Accumulation in the Retina. Investigative Ophthalmology & Visual Science, 2012; 53 (4): 2256 DOI: 10.1167/iovs.11-8569
http://www.iovs.org/content/53/4/2256

About Great HealthWorks, Inc.
Great HealthWorks, founded in 2003, is a global manufacturer and distributor of one-of-a-kind, natural products. Great HealthWorks, the makers of Omega XL, an all-natural, highly purified marine lipid extract from the green-lipped mussel (Perna Canaliculus) known as PCSO-524™. This patented marine lipid complex comes exclusively from the pristine waters of the Marlborough Sounds in New Zealand, and contains 30 healthy fatty acids. Great HealthWorks corporate headquarters and distribution center are located in Hollywood, Florida. To find out more about Great HealthWorks, visit http://www.GreatHealthWorks.com. And for more information about the benefits of Omega XL, visit http://www.OmegaXL.com. Join the conversation: http://www.facebook.com/myomegaxl


Contact